Site Sponsors
  • Park Systems - Manufacturer of a complete range of AFM solutions
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Strem Chemicals - Nanomaterials for R&D
Posted in | Nanosensors

LamdaGen Issued US Patent for Nano-Based Localized Surface Plasmon Resonance Platform

Published on April 25, 2013 at 8:41 AM

LamdaGen Corporation, a nano-technology platform company that provides plasmonic sensors and systems for diagnostics and life sciences, announced the United State Patent and Trademark Office (USTPO) issuance of patent "Enzymatic Assays for LSPR" for performing quantitative diagnostics via Localized Surface Plasmon Resonance (LSPR).

The patent claims broadly cover plasmonic surfaces and nano-particles used for LSPR-oriented ELISA. The Company's proprietary LSPR metallic thin-films are easily grown onto practically any solid support, thereby allowing compatibility with a wide range of current IVD systems — including plate-based throughput platforms and rapid diagnostic systems for Point-of-Care.

"Our plasmonic ELISA provides for rapid quantitative detection with excellent reproducibility at sensitivity levels exceeding conventional ELISAs by as much as four orders of magnitude," commented Randy Storer , CEO and Co-Founder of LamdaGen Corporation. "The issuance of this patent illustrates LamdaGen's unique ability to harness modern plasmonics for advancing In-Vitro Diagnostics (IVD)."

This patent is the latest addition to LamdaGen's growing global IP portfolio for plasmonic-based nano-applications in diagnostics, contaminant-monitoring and life science research.

Source: http://www.lamdagen.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit